MCAI Stock Overview
Pharma C Investments PLC is a venture capital firm specializing in early stage investments.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Pharma C Investments PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.0004 |
| 52 Week High | UK£0 |
| 52 Week Low | UK£0 |
| Beta | 0.094 |
| 1 Month Change | -27.27% |
| 3 Month Change | -27.27% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -95.15% |
Recent News & Updates
Recent updates
Shareholder Returns
| MCAI | GB Capital Markets | GB Market | |
|---|---|---|---|
| 7D | 0% | -1.3% | -1.4% |
| 1Y | n/a | 8.5% | -2.4% |
Return vs Industry: Insufficient data to determine how MCAI performed against the UK Capital Markets industry.
Return vs Market: Insufficient data to determine how MCAI performed against the UK Market.
Price Volatility
| MCAI volatility | |
|---|---|
| MCAI Average Weekly Movement | 6.2% |
| Capital Markets Industry Average Movement | 4.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: MCAI's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine MCAI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 2 | Toby Shillito | www.pharmacinvestments.com |
Pharma C Investments PLC is a venture capital firm specializing in early stage investments. It focuses on identifying investment opportunities in medical cannabis sector globally, with a focus on the United Kingdom, European Union, and Israel. Pharma C Investments PLC was incorporated in 2018 and is based in London, United Kingdom with an additional office in London, United Kingdom.
Pharma C Investments PLC Fundamentals Summary
| MCAI fundamental statistics | |
|---|---|
| Market cap | UK£1.23m |
| Earnings (TTM) | -UK£145.00k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-8.5x
P/E RatioIs MCAI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MCAI income statement (TTM) | |
|---|---|
| Revenue | UK£0 |
| Cost of Revenue | UK£0 |
| Gross Profit | UK£0 |
| Other Expenses | UK£145.00k |
| Earnings | -UK£145.00k |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.000047 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did MCAI perform over the long term?
See historical performance and comparison